AXSM Overview

Company Profile

Related stocks

CAI • United States

Caris Life Sciences, Inc.

29.7 USD

8.39B USD 1Y -16.5%

IMVT • United States

Immunovant, Inc.

30.47 USD

6.29B USD 1Y +88.2%

HALO • United States

Halozyme Therapeutics, Inc.

110.42 USD

12.53B USD 1Y +68.5%

IOVA • United States

Iovance Biotherapeutics, Inc.

14.62 USD

6.62B USD 1Y +486.3%

MANE • United States

Veradermics, Incorporated

130.9 USD

5.47B USD

BBIO • United States

BridgeBio Pharma, Inc.

65.35 USD

12.78B USD 1Y +17.6%

NUVL • United States

Nuvalent, Inc.

123.96 USD

9.79B USD

LGND • United States

Ligand Pharmaceuticals Incorpor

301.81 USD

6.02B USD 1Y +59.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

65.6% p.a.

Max Drawdown (5Y)

-53.5%

Sharpe Ratio (5Y)

0.56

Beta Factor

0.85

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 270%.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (65.6% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -81.3% in the extended horizon.